Abstract:Objective To evaluate effects of celecoxib (a selective cox-2 inhibitor)combined with fluvastatin (a HMG-CoA reductase inhibitor) on tumor growth and cell apoptosis in hepatocellular carcinoma xenograft in nude mice. Methods Hepatocellular carcinoma BEL-7402 cells were inoculated subcutaneously into the left armpit of nude mice, the mice (n = 32) were then randomly divided into 4 groups: the control group, the celecoxib group,the fluvastatin group and the combination group. At the end of the study,Tumor Tissues were collected for analysis. Cell apoptosis was determined by flow cytometry analysis and TUNEL assay. Akt, p-Akt and survivin protein levels were measured by Western blot. Statistical comparisons were made using factorial analysis of variance (ANOVA) and multiple comparisons between each two groups were calculated using SNK-q test. Results The combination of Celecoxib and fluvastatin resulted in a greater inhibition of tumor growth than either agent alone, the tumor inhibitory rate was 34.0% in the Celecoxib group, 25.0% in the fluvastatin group and 72.2% in the combination group. The percentages of TUNEL--positive cancer cells in the celecoxib and fluvastatin alone treatment groups were 8.5% ± 1.4% and 9.4% ±1.7% respectively as compared to the control group which was 3.5% ± 0.8%. Combination therapy showed a significantly greater increase in tumor cell apoptosis in comparison with the control and single-therapy groups (apoptotic index: 19.4% ± 3.0%; P ＜ 0.01 versus celecoxib or fluvastatin groups). The results of flow cytometry analysis also showed the same tendency. a small number of apoptotic cells were detected in the control tumours (4.1% ± 1.6%), whereas a large number of apoptotic cells were detected in tumours treated with celecoxib (9.1% ± 2.1%) or fluvastatin (10.1% ± 2.3%) alone; and the combination therapy resulted in even more apoptotic cells (23.6% ± 5.8%; P ＜ 0.01 versus celecoxib or fluvastatin groups). Western blot analysis demonstrated that the combination of celecoxib and fluvastatin significantly down-regulated p-Akt (0.23 ± 0.08 versus 1.12 ± 0.07 and surviving (0.50 ± 0.07 versus 1.47 ± 0.19) in BEL-7402 tumours compared with the control (P ＜ 0.01 for all). Conclusion The present study provided evidence that treatment with celecoxib in combination with fluvastatin resulted in the inhibition of HCC tumour growth in an in vivo mouse model. Key words: Carcinoma, hepatocellular; Mice, nude; Apoptosis; Celecoxib; Fluvastatin

Effects of Lovastatin combined with KRN633 on cholangiocarcinoma cell line QBC939

Lovastatin Inhibits Cell Proliferation and Migration in Cholangiocarcinoma Cell Line QBC939

Statins enhance anti-tumro effect of sub reoylanilide hydroxamic acid on human non-small cell lung carcinoma cells

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.

Experimental Study of Apoptosis in Leukemic Cell Lines Induced by Combined Use of Bevacizumab and Chemotherapeutic Drug

[Effect of VEGFR1 Gene Silencing by Shrna on Proliferation, Migration and Apoptosis of U937 Line].

Effects of Avastin Combined with Sorafenib in a Highly Metastatic Murine Model of Human Hepatocellular Carcinoma

Effect of simvastatin on cell cycle-related proteins in cholangiocarcinoma cells

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

Effect of Celecoxib in Combination with X-ray on the Apoptosis of Human Cholangiocarcinoma Cell Line QBC939 in Vitro

Effect of leptin on proliferation and apoptosis of cholangiocarcinoma QBC939 cells

Combined effects of celecoxib and NK Cells on growth of SMMC-7721 hepatocellar carcinoma xenografts in nude mice

Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma

Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.

Inhibition of Proliferation and Induction of Apoptosis by Simvastatin in K562 Le Ukemic Cell Line

Effect of shRNA-mediated NGF-β down-regulation on proliferation and apoptosis of human cholangiocarcinoma cells

Effects of Mucin 3A Silencing by Shrna Mediated with Lentivirus Vector on the Growth of Human Extrahepatic Cholangiocarcinoma

Anti-angiogenic and antitumor effects of anlotinib combined with bevacizumab for colorectal cancer

Effects of different delivery methods of endostatin on lung cancer and endothelial cells

Effects of Baicalein Combined with 5-Fluorouracil on Proliferation and Apoptosis in Drug-Resistant Hepatocellular Carcinoma Cell Lines

Effect of NGF-β up-regulation on the biological characteristics of human cholangiocarcinoma cell line QBC939